These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6774825)

  • 1. Cost-benefit analysis and immunization programmes in developing countries.
    Creese AL; Henderson RH
    Bull World Health Organ; 1980; 58(3):491-7. PubMed ID: 6774825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of house-to-house versus fixed-site oral poliovirus vaccine delivery strategies in a mass immunization campaign in Egypt.
    Linkins RW; Mansour E; Wassif O; Hassan MH; Patriarca PA
    Bull World Health Organ; 1995; 73(5):589-95. PubMed ID: 8846484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunizations climb, then falter.
    Kane H
    World Watch; 1994; 7(3):33-4. PubMed ID: 12287702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measles control in developing and developed countries: the case for a two-dose policy.
    Tulchinsky TH; Ginsberg GM; Abed Y; Angeles MT; Akukwe C; Bonn J
    Bull World Health Organ; 1993; 71(1):93-103. PubMed ID: 8440043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-benefit analysis of a regional system for vaccination against pneumonia, meningitis type B, and typhoid fever.
    Musgrove P
    Bull Pan Am Health Organ; 1992; 26(2):173-91. PubMed ID: 1638282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two-dose measles vaccination schedules.
    Rosenthal SR; Clements CJ
    Bull World Health Organ; 1993; 71(3-4):421-8. PubMed ID: 8324862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic analyses of rubella and rubella vaccines: a global review.
    Hinman AR; Irons B; Lewis M; Kandola K
    Bull World Health Organ; 2002; 80(4):264-70. PubMed ID: 12075361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-benefit comparisons of investments in improved water supply and cholera vaccination programs.
    Jeuland M; Whittington D
    Vaccine; 2009 May; 27(23):3109-20. PubMed ID: 19428925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating the benefits of increasing measles immunization rates.
    Zwanziger J; Szilagyi PG; Kaul P
    Health Serv Res; 2001 Oct; 36(5):885-909. PubMed ID: 11666109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic evaluation of the 7-vaccine routine childhood immunization schedule in the United States, 2001.
    Zhou F; Santoli J; Messonnier ML; Yusuf HR; Shefer A; Chu SY; Rodewald L; Harpaz R
    Arch Pediatr Adolesc Med; 2005 Dec; 159(12):1136-44. PubMed ID: 16330737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost analysis of post-polio certification immunization policies.
    Sangrujee N; Cáceres VM; Cochi SL
    Bull World Health Organ; 2004 Jan; 82(1):9-15. PubMed ID: 15106295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost benefit analysis of Japanese encephalitis vaccination program in Thailand.
    Siraprapasiri T; Sawaddiwudhipong W; Rojanasuphot S
    Southeast Asian J Trop Med Public Health; 1997 Mar; 28(1):143-8. PubMed ID: 9322297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cost-benefit analysis of typhoid fever immunization programmes in an Indian urban slum community.
    Poulos C; Bahl R; Whittington D; Bhan MK; Clemens JD; Acosta CJ
    J Health Popul Nutr; 2004 Sep; 22(3):311-21. PubMed ID: 15609784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential cost-effectiveness of annual influenza immunization for infants and toddlers: experience from Canada.
    Skowronski DM; Woolcott JC; Tweed SA; Brunham RC; Marra F
    Vaccine; 2006 May; 24(19):4222-32. PubMed ID: 16423432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benefits and costs of immunizing children against influenza at school: an economic analysis based on a large-cluster controlled clinical trial.
    Schmier J; Li S; King JC; Nichol K; Mahadevia PJ
    Health Aff (Millwood); 2008; 27(2):w96-104. PubMed ID: 18216044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunization in urban areas: issues and strategies.
    Atkinson SJ; Cheyne J
    Bull World Health Organ; 1994; 72(2):183-94. PubMed ID: 8205637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of routine immunization to control Japanese encephalitis in Shanghai, China.
    Ding D; Kilgore PE; Clemens JD; Wei L; Zhi-Yi X
    Bull World Health Organ; 2003; 81(5):334-42. PubMed ID: 12856051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-benefit analysis of a rotavirus immunization program in the Arab Republic of Egypt.
    Ortega O; El-Sayed N; Sanders JW; Abd-Rabou Z; Antil L; Bresee J; Mansour A; Adib I; Nahkla I; Riddle MS
    J Infect Dis; 2009 Nov; 200 Suppl 1():S92-8. PubMed ID: 19817621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benefits, cost requirements and cost-effectiveness of the HPV16,18 vaccine for cervical cancer prevention in developing countries: policy implications.
    Goldie SJ; O'Shea M; Diaz M; Kim SY
    Reprod Health Matters; 2008 Nov; 16(32):86-96. PubMed ID: 19027626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness appraisal of immunization programmes.
    Creese AL; Sriyabbaya N; Casabal G; Wiseso G
    Bull World Health Organ; 1982; 60(4):621-32. PubMed ID: 6814777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.